Prescription semaglutide and other GLP-1 receptor agonists are regulated medicines with studied formulations, dosing, and monitoring
Population-targeted RCT (12 weeks) A multicenter clinical study involving 90 women aged 3350 years evaluated 500 mg/day of oral glutathione over 12 weeks
BPC-157 Peptide Therapy for Recovery and Gut Health Conveniently located to serve the areas of Walnut Creek, Concord, Pleasant Hill, Danville, San Ramon, Lafayette, Orinda and Pleasanton, CA BPC-157 therapy* is a specialized treatment that utilizes the peptide BPC-157 to help support a variety of patient goals, including supporting recovery and promoting better gut health
We have to be very careful with brands coming in and saying, Oh, I have something that could potentially help the GLP-1 pathway, so were going to call this the GLP-1 [supplement]. Or, I have something that could maybe reduce your hunger a little bit